Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab

A. Egeberga Department of Dermatology, Bispebjerg Hospital, Copenhagen, DenmarkCorrespondence[email protected]
View further author information

L. Iversenb Department of Dermatology, Aarhus University Hospital, Aarhus, DenmarkView further author information

A. B. Kimballc Harvard Medical School and Beth Israel Deaconess Hospital, Boston, MA, USAView further author information

S. Kellyd Eli Lilly and Company, Indianapolis, IN, USAView further author information

E. Graced Eli Lilly and Company, Indianapolis, IN, USAView further author information

H. Pateld Eli Lilly and Company, Indianapolis, IN, USAView further author information

W. Xud Eli Lilly and Company, Indianapolis, IN, USAView further author information

G. Gallod Eli Lilly and Company, Indianapolis, IN, USAView further author information

E. Riedld Eli Lilly and Company, Indianapolis, IN, USAView further author information

S. R. Feldmane Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.